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The CDR1 and Other Regions of 
Immunoglobulin Light Chains are 
Hot Spots for Amyloid Aggregation
Robin Axel Ruiz-Zamora1, Simon Guillaumé2, Youssra K. Al-Hilaly  2,3, Zahraa Al-Garawi2,3, 
Francisco Javier Rodríguez-Alvarez1, Guadalupe Zavala-Padilla4, Julio I. Pérez-Carreón1, 
Sandra L. Rodríguez-Ambriz5, Guillermo A. Herrera6, Baltazar Becerril-Luján4,  
Adrián ochoa-Leyva  4, Jorge Melendez-Zajgla  1, Louise Serpell  2 & Luis del Pozo-Yauner  1,6
Immunoglobulin light chain-derived (AL) amyloidosis is a debilitating disease without known cure. 
Almost nothing is known about the structural factors driving the amyloidogenesis of the light chains. 
This study aimed to identify the fibrillogenic hotspots of the model protein 6aJL2 and in pursuing this 
goal, two complementary approaches were applied. One of them was based on several web-based 
computational tools optimized to predict fibrillogenic/aggregation-prone sequences based on different 
structural and biophysical properties of the polypeptide chain. Then, the predictions were confirmed 
with an ad-hoc synthetic peptide library. In the second approach, 6aJL2 protein was proteolyzed with 
trypsin, and the products incubated in aggregation-promoting conditions. Then, the aggregation-prone 
fragments were identified by combining standard proteomic methods, and the results validated with 
a set of synthetic peptides with the sequence of the tryptic fragments. Both strategies coincided to 
identify a fibrillogenic hotspot located at the CDR1 and β-strand C of the protein, which was confirmed 
by scanning proline mutagenesis analysis. However, only the proteolysis-based strategy revealed 
additional fibrillogenic hotspots in two other regions of the protein. It was shown that a fibrillogenic 
hotspot associated to the CDR1 is also encoded by several κ and λ germline variable domain gene 
segments. Some parts of this study have been included in the chapter “The Structural Determinants of 
the Immunoglobulin Light Chain Amyloid Aggregation”, published in Physical Biology of Proteins and 
Peptides, Springer 2015 (ISBN 978-3-319-21687-4).
Immunoglobulin light chain (AL) amyloidosis is a serious disease characterized by the systemic deposition, in the 
extracellular compartment, of a monoclonal free light chain as insoluble fibrils1. Despite the progress achieved 
in the last two decades in the therapeutic management of AL-amyloidosis2,3, it remains as an incurable and often 
fatal disease. To some extent, this is due to the insufficient understanding regarding the structural factors that 
drive the amyloidogenesis of the light chains. This has halted the development of more effective therapeutic 
approaches aiming to suppress the key molecular event of the disease pathogenesis: the misfolding of the light 
chain and its subsequent self-assembly into the ordered amyloid fibrils4,5. However, misfolding can also result 
in light chains forming a non-fibrillar structure6–8. Since the specific microscopic ordering adopted by the light 
chain in the tissue deposits has a strong influence on the clinical course of the disease9, there is much interest in 
understanding what makes a light chain amyloid-prone. There is an increasing body of evidence indicating that 
the ability of a protein to form amyloid fibrils is contained in short stretches of its sequence, known as fibrillogenic 
hotspots10. As a distinctive property, these protein segments can autonomously form fibrillar aggregates with 
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characteristics of amyloid11. Moreover, it has been shown that the aggregation of the full-length amyloid pre-
cursor can be modulated by targeting their fibrillogenic region(s) with site-directed mutagenesis or by the bind-
ing with specific ligands12,13. Correspondingly, a naturally non-amyloidogenic protein can be converted into an 
amyloid-prone one by inserting into its sequence non-destabilizing short amyloid-forming segments taken from 
an amyloidogenic polypeptide10. X-ray diffraction studies of microcrystals formed by fibrillogenic peptides have 
revealed that they can form a variety of cross β spines, composed of β-sheets running along the longitudinal axis 
of the crystal lattice, with the amino acid side chains interdigitated in a complementary dry “steric zipper”14,15. It 
is thought that the steric zipper is the structural motif characterizing the amyloid fibril core. Information regard-
ing the characteristics of the fibrillogenic sequences of the light chains is very scarce. The identification of such 
sequences is critical for understanding the structural basis of amyloidogenesis of the light chains. Moreover, 
this could foster the development of better therapeutic and/or diagnostic strategies in AL amyloidosis, since the 
pro-fibrillogenic hot-spots represent potential targets for theranostic agents16. Thus, this study aimed to iden-
tify the fibrillogenic hotspots of the model protein 6aJL217, a recombinant (r) light chain variable domain (VL) 
encoded by the λ6 germline gene segment IGLV6-57 (6a). Previous studies have shown that the light chains 
encoded by IGLV6-57, the only gene segment composing the λ6 subgroup, display a high propensity to aggregate 
as amyloid in vivo18–22. With only one clinically proven exception23, all monoclonal λ6 light chains identified 
so far has been shown to be involved in amyloid deposition22. Moreover, we have shown that 6aJL2 can form 
amyloid-like fibrils in physiological relevant conditions of pH, temperature, and ionic strength24. These findings 
suggest that as yet unidentified amyloidogenic sequences encoded in the germline IGLV6-57 could be part of the 
structural factors that make λ6 light chains highly prone to aggregate as amyloid fibrils17,24,25. Being a protein with 
germline sequence, 6aJL2 is an ideal model to study the contribution of germline-encoded fibrilogenic sequences 
to the propensity of the λ6 light chains to aggregate as amyloid. For this purpose, an experimental strategy com-
posed by two complementary approaches was applied (Fig. S1). In one approach, the sequence of 6aJL2 protein 
was scanned with two web-based computational tools, ZypperDB26,27 (http://services.mbi.ucla.edu/zipperdb/) 
and AmylPred228 (http://aias.biol.uoa.gr/AMYLPRED2/), optimized to predict fibrillogenic/aggregation-prone 
sequences based on different structural and biophysical properties of the polypeptide chain. Then, the predictions 
were confirmed with an ad-hoc synthetic peptide library. In the second approach, protein 6aJL2 was proteolyzed 
with trypsin, and the products were incubated in aggregation-promoting conditions. Then, the aggregation-prone 
fragments were identified by combining standard proteomic methods, and the results validated by analysing 
the aggregation behaviour of a set of synthetic peptides with the sequence of the tryptic fragments. Both strat-
egies coincided to identify a fibrillogenic hotspot located at the CDR1 and β-strand C of the protein, which 
was confirmed by scanning proline mutagenesis analysis. However, only the proteolysis-based strategy revealed 
additional fibrillogenic hotspots in two other regions of the protein. Furthermore, we show that a fibrillogenic 
hotspot centre within the CDR1 is also encoded by other germline gene segments belonging to different κ and λ 
VL subgroup, indicating the general applicability of our findings for AL.
Results
Computational prediction of fibrillogenic/aggregation-prone sequences. ZipperDB identified 21 
hexamers in the 6aJL2 protein forming steric zippers with a fit energy calculated with Rosetta of −23 kcal/mol 
or lower. Segments with Rosetta energy equal to or below −23 kcal/mol are deemed to have high fibrillation 
propensity27 (Fig. 1). These hexamers cluster in four regions of the domain, the β-strand B, the Complementary 
Determining Region 1 (CDR1), the region spanning the β strands D and E, and that spanning the β-strand F, 
CDR3 and β-strand G (Fig. 1)29. AmylPred2 identified five fibrillogenic/aggregation-prone consensus sequences, 
which overlap with those identified by ZipperDB (Fig. 2)29.
Aggregation assay of the prediction-based synthetic peptides. Based on the predictions gen-
erated by the tools ZipperDB and AmylPred2, a synthetic peptide library, composed by 31 hexapeptides and 
one decapeptide, was designed (Fig. 3A and Table S2). The library was composed by 21 hexamers with Rosetta 
energy of −23 kcal/mol or lower, and 10 hexamers with Rosetta energy higher than −23 kcal/mol, predicted by 
ZipperDB to have low propensity to form amyloid27. The decapeptide 30IASNYVQWYQ37 was included, as it was 
recognized as potentially fibrillogenic by four of ten predictors consulted by the algorithm AmylPred228. The 
aggregation behaviour of the synthetic peptides composing the prediction-based peptide library was assayed as 
described in Methods. After 24 hours of incubation, only the samples of the decamer Ile30-Gln37 and the hexam-
ers Ile30-Val33 and Ser30b-Trp35 displayed cloudy appearance suggesting the presence of insoluble aggregates, 
but only those formed by Ile30-Gln37 displayed fluorescence in presence of ThT (Fig. 3B)29.
Transmission Electron microscopy (TEM). Peptide Ile30-Gln37 formed fibrils that associate in bundles, 
as well as large and irregular aggregates with crystalline morphology (Fig. 3C,D). Also, long and straight rod-like 
aggregates were observed, some of them associated in pairs (Fig. S3A). The hexapeptide Ile30-Val33 formed 
fibrils (Fig. 3E), while Ser30b-Trp35 formed paracrystalline aggregates of different morphology. Some were irreg-
ular (Fig. 3F), others were needle-like (Fig. S3C) or large and faceted (Fig. 3G). Long rod-like fibrous crystals 
were also observed (Fig. 3H and S3D). It is worth mentioning that both hexapeptides, Ile30-Val33 (30IASNYV33) 
and Ser30b-Trp35 (30bSNYVQW35), are contained within the sequence of Ile30-Gln37 (30IASNYVQWYQ37). No 
needle-like fibrous crystals or fibrils were observed in the remaining samples.
Far-UV Circular Dichroism Spectroscopy. Despite having shown ThT fluorescence and fibrillar morphol-
ogy under TEM, the Far-UV CD spectrum of the end-point aggregates of peptide Ile30-Gln37 was not typical of 
β conformation (Fig. 4A). Instead, it featured a band of negative ellipticity centred at 235 nm, and a second one 
of positive ellipticity with a maximum around 203 nm, a pattern probably determined by the aromatic moiety of 
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the Tyr residues present in the peptide. Far-UV CD spectra characterized by one or more minima and maxima at 
different wavelength were also displayed by the hexapeptides with aromatic residues, in contrast to those with no 
aromatic residues, which displayed spectra characteristic of an unstructured polypeptide, both before and at the 
end of the incubation (Fig. S4).
XRFD analysis of aggregates formed by synthetic peptides. To produce material suitable for X-ray 
fiber diffraction (XRFD) analysis, the peptides Ile30-Val33, Ser30b-Trp35, and Ile30-Gln37 were aggregated in the 
same conditions of temperature and speed of agitation used in the fibrillogenesis assays, but, instead of dissolving 
in PBS pH 7.4, the peptides were solubilized in milli-Q water plus 0.05% Na azide. Peptide Ile30-Val33 formed 
needle-like aggregates (Fig. S5A–C), while Ser30b-Trp35 formed rod-like fibres, large cylindrical aggregates of 
variable diameter and length, and irregular paracrystalline aggregates similar to those formed in PBS pH 7.4 
(Fig. 5D and S5D–F). Ile30-Gln37 formed abundant aggregates with the appearance of long rigid fibrils, as well 
as thin needles (Fig. 5E and S5G–I). XRFD patterns from partially aligned aggregates of peptides Ser30b-Trp35 
and Ile30-Gln37 showed the major reflections expected for amyloid30,31, with a strong diffraction signal on the 
meridian (vertical) at 4.7 Å (Fig. 5A,B). The position of all diffraction signals is shown in Table S6. Each pattern 
showed a series of very sharp equatorial diffraction signals arising from the crystalline morphology of the fibril-
lar structures. Ser30b-Trp35 gave rise to a sharp and strong diffraction signal at 9.77 Å which is commensurate 
with a β-sheet spacing for a steric zipper arrangement (Fig. 5A). The diffraction pattern for Ile30-Gln37 showed 
several equatorial signals with similar intensities at 12.4 Å, 11 Å and 8.1 Å (Fig. 5B and Table S6). Both diffrac-
tion patterns showed low angle diffraction signals at 21 Å and 18.2 Å for Ser30b-Trp35 and 22 Å for Ile30-Gln37 
(Table S6). Ser30b-Trp35 equatorial diffraction signal at 18.2 Å may arise from the arrangement of two β-strands 
separated by 9.77 Å oriented antiparallel to one another. 21 Å is approximately the chain length for a hexapeptide 
(3.5 Å x6). The structural model for the steric zipper of the peptide Ser30b-Trp35, generated by the computa-
tional tool ZipperDB, was arranged into a unit cell with dimensions 21 Å × 18.2 Å × 4.73 Å, α = β = γ = 90° and 
the diffraction pattern was calculated to enable the model structure to be compared to the experimental data 
(Fig. 5C,F). Several major diffraction signal positions, on the equator as well as meridian, match well between 
the calculated and experimental XRFD patterns. The diffraction pattern from Ile30-Gln37 gives the lowest visible 
and measurable angle signal at 22 Å. However, careful examination of the pattern reveals a lower angle diffraction 
peak, very close to the back stop which may suggest a lower angle signal is present. The length of an extended 
Figure 1. Segments of 6aJL2 protein predicted to be fibrillogenic by the computational tool ZipperDB26,29 
(https://services.mbi.ucla.edu/zipperdb/). The hexamers shown are those with a Rosetta energy ≤−23 kcal/
mol, which are predicted to form fibrils27. The location of the clusters of the amyloidogenic hexamers is 
shown highlighted in magenta in the three-dimensional structure of 6aJL2 protein (bottom). The regions of 
6aJL2 protein with β-strands or helix conformation in the native state are indicated by arrows and cylinders, 
respectively (Top). The oval figures in the first and last arrows represent, respectively, the sheet-switch motif 
characterizing the structure of the N-terminal segment, and the β-bulge centred at Gly100 in the β-strand 
G. The residue numbering and the location of the CDR/FR regions are according to Chothia and Lesk69. The 
graphical representations of 6aJL2 structure were prepared with PyMOL70, based on the structure contained in 
the PDB 2W0K.
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β-strand with 10 amino acid residues is approximately 33 Å, which may align well with the weak low angle equa-
torial signal. Alternatively, the 10 residues peptide may form a bend similar to previous structures published for 
amyloid peptides32,33. The diffraction signals at 22 Å and 11 Å may be related and the 11 Å may represent the sheet 
spacing which would accommodate the large and bulky side chains. A unit cell a = 32 Å, b = 22 Å, c = 4.72 Å, 
α = β = γ = 90° could explain the observations at 8.1 Å [4 0 0], 16 Å [2 0 0] and 11 Å [0 2 0].
Proteolysis of 6aJL2 protein with trypsin. The increasing knowledge about the amino acid sequences 
conferring propensity to form amyloid have stimulated the development of several computational algorithms 
optimized to recognize such aggregation hot-spots34. Most of these methods rely solely on the sequence anal-
ysis, thus they are relatively ineffective for identifying aggregation-prone sites that may be non-contiguous in 
sequence; buried inside the native structure, or dependent on structural factors restricting the conformational 
freedom in the context of a globular protein, such as disulphide bonds35. Based on this argument, a second exper-
imental approach, based on limited proteolysis of 6aJL2 protein was applied. This approach is based on the obser-
vation that bulky and charged residues, as well as proline, tend to be positioned at the flanks of aggregation-prone 
regions in globular proteins, a pattern that is believed to be evolutionarily selected to control protein aggrega-
tion36,37. In agreement with this observation, it was found that the regions of 6aJL2 predicted as fibrillogenic by the 
web-based tool AmylPred2 are flanked by Arg or Lys residues (Fig. S7). As trypsin cleaves the peptide backbone 
at the C-terminal side of Arg and Lys residues, we hypothesized that this protease can be used for releasing frag-
ments of 6aJL2 protein bearing aggregation-promoting sequences whose aggregation depends on driving forces 
not considered by the computational tools used. In two (Arg39 and Arg54) of the seven trypsin cleavage sites 
distributed along the sequence of 6aJL2 protein, a proline residue occupies the C-terminal contiguous position 
(Fig. S8), which is predicted to severely decrease the cleavage probability (http://web.expasy.org/peptide_cutter/). 
However, fragments generated by cleavage at these sites appeared early during the proteolysis of the native pro-
tein (Fig. S9). The RP-HPLC profile of the end-point products of the proteolysis of 6aJL2 protein (described in 
Method), as well as the identity of each proteolytic fragment, as determined by MALDI-TOF mass spectrometry 
(MS) analysis, are shown in Fig. 6.
Figure 2. Consensus sequences (CONSENSUS-5) generated by the AmylPred2 tool from the analysis of the 
6aJL2 protein with 10 different algorithms designed for predicting aggregation/fibrillogenic-prone sequences28. 
The individual prediction of each method is also shown. The regions of 6aJL2 protein with β-strands or helix 
conformation in the native state are indicated as in Fig. 1. The residue numbering and the location of the CDR/
FR regions are according to Chothia and Lesk69. The graphical representations of 6aJL2 structure were prepared 
with PyMOL70, based on the structure contained in the PDB 2W0K.
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Fibrillogenesis of the tryptic fragments of 6aJL2 protein. Once the proteolysis of 6aJL2 protein with 
trypsin was completed, the products were incubated as described in Methods. The amyloid formation was deter-
mined by ThT assay, while the identification of the aggregated fragments was performed by RP-HPLC combined 
with MALDI-TOF MS (see Methods). The fragment that appeared earliest in the aggregates was Ser26-Arg39, 
eluted with an average retention time of 27.99 minutes (Fig. 7A). The chromatographic peak corresponding to this 
fragment showed the largest signal increase (absorbance at 216 nm) during the first seven hours of incubation, 
matching well with the variation of the ThT fluorescence (Insert at Fig. 7A). This suggests that the aggregation of 
the fragment Ser26-Arg39 accounted for most of the ThT fluorescence increase observed in that time frame. After 
18 hours of incubation, the ThT fluorescence remained constant, suggesting that the fibrillogenesis reaction had 
reached completion. TEM analysis of the end-point sample showed the presence of fibrillar aggregates (Fig. 7D). 
RP-HPLC/MALDI-TOF MS analysis showed that the most abundant components of the aggregates were frag-
ments Thr18-Arg25-S-S-Thr80-Lys103, Phe62-Lys79, Ser26-Arg39, and Ser26-Arg54 (Fig. 7B,C). The location of 
the aggregation-prone fragments into the native structure of 6aJL2 protein is shown in Fig. 7E. Note that fragment 
Thr18-Arg25-S-S-Thr80-Lys103 is composed by segments Thr18-Arg25 and Thr80-Lys103 linked by the highly 
conserved intradomain disulphide bond Cys23-Cys88.
Fibrillogenesis of synthetic peptides with the sequence of the tryptic fragment of 6aJL2 protein. 
The incubation of the products of proteolysis of 6aJL2 protein with trypsin resulted in the formation of fibrillar 
aggregates with the properties of amyloid (Fig. 7). This finding indicates that at least one of the tryptic frag-
ments identified in the aggregates can form this type of aggregate. To unambiguously determine which of the 
tryptic fragments is capable to form amyloid-like fibrils, the aggregation behaviour of seven synthetic peptides 
with the sequence of the fragments generated by the protease was investigated (Fig. S8). Peptides Ser26-Arg39, 
Ser26-Arg54 and Phe62-Lys79 formed fibrillar aggregates that give positive ThT fluorescence (Fig. 8A), correlat-
ing with the aggregation assay of the tryptic fragments. The far-UV CD spectra of the fibrillar aggregates of pep-
tides Ser26-Arg39 and Phe62-Lys79 is shown in Fig. 4B,D, respectively. Peptides Asn1-Lys17 and Pro40-Arg61 
Figure 3. (A) Prediction-based synthetic peptide library composed of thirty-one hexapeptide and one 
decapeptide designed for testing the predictions of fibrillogenic/aggregation prone sequences in the rVL protein 
6aJL229 generated by the web-based computational tools ZipperDB26 and AmylPred228. The arrows point the 
consensus sequences predicted to be aggregation/fibrillogenic-prone by the tool AmylPred2. The sequences 
underlined and italized represent the hexapeptides forming steric zippers with a fit energy of −23 kcal/mol or 
lower, as calculated with RosettaDesign71. Segments with energies equal to or below this threshold are deemed 
to have high fibrillation propensity27. (B) Aggregation assay of the synthetic peptides composing the prediction-
based peptide library. The data represented is the thioflavin T (ThT) fluorescence intensity of the peptide 
samples (250 µM peptide dilution in PBS pH 7.4 plus 0.05% Na Azide), measured after 24 hours of incubation at 
37 °C with constant agitation. Two replicas of the experiment were performed with very similar results (Result 
not shown). (C–H) Transmission electron micrographs of the aggregates present in the end-point samples of 
the synthetic peptides Ile30-Gln37 (C,D), Ile30-Val33 (E), and Ser30b-Trp35 (F–H).
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did not form aggregates, which is consistent with the results of the aggregation assay of the tryptic fragments 
(Fig. 7). Surprisingly, the peptides Thr18-Arg25 and Thr80-Lys103 did not aggregate either (Fig. 8A), an unex-
pected finding given that they form the disulphide-linked tryptic fragment that was recovered from the aggre-
gates at the end of the incubation (Fig. 7).
Fibrillogenesis of the tryptic fragment Thr18-Arg25-S-S-Thr80-Lys103 in reducing and 
non-reducing conditions. The absence of aggregation of the synthetic peptides Thr18-Arg25 and 
Thr80-Lys103 when incubated separately suggests that the conservation of the disulphide bond Cys23-Cys88 
may be a requirement for the aggregation of the whole fragment. To test this hypothesis, the disulphide-linked 
fragment was purified by RP-HPLC in non-reducing conditions from an overnight digestion of 6aJL2 protein. 
Then, its aggregation behaviour was evaluated at 150 μM diluted in PBS pH 7.4, in reducing (10 mM of DTT) and 
non-reducing (absence of DTT) conditions. Fragment Thr18-Arg25-S-S-Thr80-Lys103 incubated in absence of 
DTT formed long fibrils with ThT binding capacity (Fig. 8E,F), but very scarce fibrils were observed in the sample 
incubated with DTT (Fig. 8E,G). The far-UV CD spectrum of the fibrils of Thr18-Arg25-S-S-Thr80-Lys103 is 
characteristic of β-sheet conformation (Fig. 4C). This result shows that, at least in the condition set in this study, 
the ability of the fragment Thr18-Arg25-S-S-Thr80-Lys103 to form amyloid-like fibrils depends on the conserva-
tion of the disulphide bond Cys23-Cys88.
Scanning Proline (Pro) mutagenesis analysis of Ser26-Arg39 peptide. The prediction-based 
approach was successful in detecting a fibrillogenic sequence spanning from Ile30 to Gln37, which is located in 
the CDR1 and the β-strand C. This segment is part of the tryptic fragment Ser26-Arg39. Thus, we wanted to iden-
tify the residues forming the β-sheet core of Ser26-Arg39 fibrils. For such purpose, a scanning proline mutagen-
esis analysis was performed with a set of synthetic peptides with single substitutions to Pro (Table S10). Since 
the wild-type (WT) peptide Ser26-Arg39 showed an extremely high propensity to aggregate upon solubilization 
in PBS pH 7.4, preliminary aggregation experiments were performed in presence of increasing concentration of 
GdnHCl for determining the conditions suitable for preparing a stable solution of the peptide (Suppl text S15). It 
was found that WT peptide Ser26-Arg39 can form amyloid-like fibrils in presence of GdnHCl up to 3.0 M after 
40 hours of incubation (Fig. S16). Based on this result, it was decided to perform the aggregation assay with the 
single mutants to Pro in presence of 2.0 M of GdnHCl. Figure 9A,B show the ThT fluorescence and the Trp flu-
orescence of the soluble fraction of the samples determined after sixteen and forty hours of incubation, respec-
tively. TEM analysis showed abundant fibrils in all samples that displayed ThT fluorescence. The size and shape 
of the fibrils were homogeneous in this set (Fig. 9C–F,H), with the notable exception of the mutant Gln38Pro, 
whose fibrils were shorter and tended to curve, and rather than associate in bundles, they were evenly distributed 
Figure 4. Far-UV circular dichroism spectra of peptide (A) Ile30-Gln37, (B) Ser26-Arg39, (C) tryptic fragment 
Thr18-Arg25-S-S-Thr80-Lys103, and (D) Phe62-Lys79 before (yellow circles) and after (blue squares) the 
fibrillogenesis assay, performed as described in Methods.
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throughout the grid (Fig. 9G). The data indicate that the region spanning from Ile30 to Tyr36 is sensitive to Pro 
replacement. Significantly, the replacement of Gln37 to Pro inhibited the aggregation of Ser26-Arg39 after 16 hours 
of incubation, but not after 40 hours. This suggests that Gln37 is probably at the edge of the Pro-sensitive region.
In vitro fibrillogenesis of the Ser26-Arg39-homologous synthetic peptides. The finding of a fibril-
logenic hotspot in the CDR1 of 6aJL2 protein raised the question whether it is specific to λ6 light chains or is 
shared by light chains belonging to other VL subgroups. To explore this question, 26 peptides structurally homol-
ogous to Ser26-Arg39 were monitored for amyloidogenesis (Table S11). These peptides are encoded by several 
VL gene segments belonging to the VL subgroups κ1, κ4, λ1, λ2, and λ3, which, together with gene IGLV6-57, 
encode 793 of 808 AL sequences compiled at ALBase (http://albase.bumc.bu.edu/aldb/). The criterium of selec-
tion was the frequency of each individual VL gene segments in the AL sequences compiled at ALBase. From each 
VL subgroups, one gene segment with high frequency, one with middle frequency and one with low frequency, or 
not present among the AL sequence, were choose. According to the ThT fluorescence assay, five of eleven λ pep-
tides (∼45%) and ten of thirteen κ peptides (∼77%) formed amyloid-like aggregates (Fig. S12). Two third of the 
peptides belonging to the λ1 and λ2 subgroups formed amyloid. In contrast, only one (3λ−3l) of five λ3 peptides 
displayed even minor increase in ThT fluorescence. Among the κ peptides, only κ1-A30/L11 and the two κ2 pep-
tides did not form amyloid. Some peptides, as Ser26-Arg39 (identified as λ6-6a), 2-2b2, κ1-L1, κ1-L15/L5/L19 
and κ3-L6, appear to aggregate faster than others, since they reached the highest ThT fluorescence value before 
24 hours of incubation (Fig. S12). There were also differences between peptides regarding the maximum value of 
ThT fluorescence reached. In general, good agreement between the variations of ThT fluorescence and the soluble 
fraction was observed (Fig. S12). TEM analysis established the fibrillar morphology of most aggregates, although 
extensive structural heterogeneity between samples, as well as intrasample was observed (Fig. 10).
Discussion
It this study, two complementary approaches were applied to identify the fibrillogenic hot-spots of the rVL 6aJL2 
protein. One relied on the predictions of fibrillogenic/aggregation prone sequences performed by two compu-
tational tools26,28, and the other took advantage of limited proteolysis with trypsin for releasing fragments of 
6aJL2 with aggregation-prone sequences, whose aggregation behaviour was subsequently assayed. In general, 
the computational predictions match well with the experimental results, since most of the sequences predicted 
to be aggregation prone are within the peptide segments that formed amyloid-like fibrils in vitro (Fig. 11). This 
Figure 5. X-ray fibre diffraction (XRFD) patterns from partially aligned fibrils formed by synthetic peptides 
(A) Ser30b-Trp35 and (B) Ile30-Gln37 incubated in MilliQ-quality water plus Na azide 0.05%, as described 
in Methods. (D,E) show transmission electron micrographs of the aggregates whose XRFD pattern are shown 
in panels A and B, respectively. The images were obtained with a HITACHI-7100 transmission electron 
microscope (C). Comparison of the experimental XRFD pattern of the aggregates of the peptide Ser30b-Trp35, 
as shown in (A), and the simulated pattern (inserted quadrant) calculated based on the theoretical model 
shown in (F). Black arrows are shown to highlight positions of matching major diffraction signal positions on 
the equator and meridian. (F) Structural model of the steric zipper of peptide Ser30b-Trp35, generated by the 
computational tool ZipperDB26. The amino acid side chains are shown in stick representation and named with 
the one-letter code. The dotted lines represent intra- and interpeptide H-bonds stabilizing the crystal lattice. 
Figure prepared with PyMOL70.
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shows that both tools, ZypperDB and AmylPred2, were able to accurately identify the regions of 6aJL2 pro-
tein whose sequence pattern is compatible with a stable amyloid assembly. However, the proteolysis-based 
strategy was more successful than the prediction-based approach in detecting the aggregation-prone regions. 
While both strategies identified a fibrillogenic hotspot spanning the CDR1 and β-strand C of the protein, 
only the proteolysis-based strategy revealed the presence of additional fibrillogenic hotspots in the fragments 
Thr18-Arg25-S-S-Thr80-Lys103 and Phe62-Lys79. The structural characteristics of these tryptic fragments sug-
gest why the prediction-based strategy failed to detect them. Thr18-Arg25-S-S-Thr80-Lys103 is composed by two 
peptide segments covalently linked by the disulphide bond Cys23-Cys88 (Fig. 7E). Since the experimental data 
indicate that the ability of the fragment to form fibrils depends on the conservation of this covalent link (Fig. 8), 
it can be deduced that the conformational restrictions it imposes contribute critically to the mechanism of fibril 
assembly and/or stability. It is worth mentioning that some light chains can form amyloid-like aggregates under 
reducing conditions, which indicates that the preservation of the disulphide bond Cys23-Cys88 is not a general 
requirement for light chain amyloidogenesis38,39. Therefore, in a reducing environment, the fibrillogenesis of at 
least some light chains appears to be driven by hot spots not dependent on the disulphide bond. One would 
expect that, under such conditions, the pre-fibrillar and fibrillar aggregates formed would be structurally differ-
ent from those formed by the molecules with the intact Cys23-Cys88 bond, and most importantly, would exhibit 
different biological properties.
On the other hand, the dodecamer Phe62-Lys79 comprises the β strands D and E, both of six residues in 
length (Fig. 7E). As neither of the hexamers predicted to be fibrillogenic within Phe62-Lys79 formed amyloid-like 
fibrils in our aggregation assay (Fig. 3), it cannot be excluded that the fibrillogenesis of this fragment is driven 
by cooperative contacts between amyloid stretches located relatively distant in its linear sequence, but that are 
clustered once aggregation occurs40. Fibrillar Phe62-Lys79 may adopt a β arch conformation, a recurring struc-
tural motif in both, functional and pathological amyloids41, so that the regions corresponding to the β-strands 
D and E contact each other via their side chains to form a heterosteric zipper and not via the peptide backbone, 
as occurs in the native protein. Neither of the computational algorithms available for predicting fibrillogenic/
Figure 6. (A) RP-HPLC elution profile of the products of the proteolysis of soluble 6aJL2 protein with trypsin. 
Prior to be injected into the column, the sample was reduced by adding 10 mM dithiothreitol (DTT). The data 
represented are the time-dependence variation of (black line) absorbance at 216 nm or (blue line) intrinsic 
fluorescence at 350 nm, exciting the sample at 295 nm. (B) Identification of the proteolytic fragments of 6aJL2 
protein contained in the chromatography fractions collected in A) by MALDI-TOF mass spectrometry analysis. 
arefers to the fractions identified with the same letter code in panel (A). R.T./min refers to the retention time 
(minutes) of each fraction in the RP-HPLC analysis. brefers to the mass (Da) determined experimentally 
by MALDI-TOF mass spectrometry analysis. crefers to the segment of protein 6aJL2 identified as the best-
matching sequence for each experimental mass determined by means of the web-based computational tool 
FindPept (http://web.expasy.org/findpept/).
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aggregation-prone sequences has been optimized for dealing with the complex structural constraints that appear 
to drive the aggregation of these fragments34. For comparative purpose, the peptide concentration (250 μM), 
incubation time (24 h) and pH (7.4) chosen for assaying the prediction-based peptide library was based on those 
optimised for testing the aggregation of the tryptic fragments of 6aJL2 protein. It cannot be excluded that such 
conditions could have limited the capacity of some hexapeptides to aggregate. For example, Ivanova, M.I. et al. 
Figure 7. RP-HPLC analysis of (A) the aggregates harvested serially during the first seven hours (0, 15 min, 
30 min, 45 min, 1 h, 2 h, 3 h, 4 h, 5 h, 6 h and 7 h) and (B) after 18 hours of incubation (see Methods) of the 
products of the proteolysis of 6aJL2 protein with trypsin. The data represented in A and B is the absorbance at 
216 nm. In B, the chromatographic profiles of the aggregates analysed in non-reducing (black line) and pre-
incubated with 10 mM of DTT (blue line) are shown. Note that the peak with R.T. = 25.47 min, which represent 
the elution of the fragment Thr18-Arg25-S-S-Thr80-Lys103, is absent in the chromatogram of the reduced 
sample. Instead, two new peaks appear, with R.T. = 19.36 min and 26.07 min, respectively, which represent 
the separate elution of the individual peptides. (C) Identification of the proteolytic fragments of 6aJL2 protein 
contained in the fractions of the chromatography separation shown in panels B). a, band cmean the same as in 
Fig. 6. (D) Electron micrograph of the aggregates harvested after the overnight incubation of the products of 
proteolysis of the 6aJL2 protein with trypsin. (E) Proteolytic fragments recovered from the aggregates after the 
overnight incubation of the products of proteolysis of the protein with trypsin, as determined by combining RP-
HPLC and MALDI-TOF mass spectrometry. The structural contribution of each fragment to the native 6aJL2 
protein is shown with reference to the crystallographic structure of the protein (PDB ID 2W0K).
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set peptide concentration and incubation time at 2 mM and up to 45 days respectively, for assaying a set of 59 
hexapeptides designed for screening β2-microglobulin and insulin for amyloid-like forming sequences11. They 
found that eight hexapeptides (13.6%) formed amyloid-like aggregates, a higher aggregation rate compared to this 
study, as only two hexapeptides of 31 formed amyloid-like aggregates (6.5%). However, differences in the incu-
bation buffer (pH = 2.5 in M.I. Ivanova and coworkers11), could also contribute to such difference. On the other 
hand, the relatively stringent conditions used in this study revealed the highly fibrillogenic sequence Ile30-Gln37.
This segment is similar to the sequence stretch found to be sensitive to proline replacement (Fig. 9). It is 
well known that proline is energetically unfavourable in β-sheet conformations42,43, a property that has been 
successfully used for mapping the secondary structure of the amyloid fibril formed by Aβ(1-40)44, and amylin45. 
It can be anticipated that the segment Ile30-Tyr36 is structured in the fibrillar peptide Ser26-Arg39, forming 
the β-sheet rich fibril core. The high capability of Ile30-Gln37 to self-assemble into fibrils very probably reflects 
the properties of the hexamer 30bSNYVQW35, as it was shown that this can assemble into highly ordered parac-
rystalline aggregates, including long cylindrical fibrous crystals (Figs 3F–H, 5D and S5D–F). Such behaviour 
has been linked to high amyloid propensity15,26. The XRFD analysis suggests that, in the crystal lattice, peptide 
Ser30b-Trp35 arranges as an antiparallel dimer, whose interface is stabilized by a tight homosteric zipper centred 
on Tyr32 (Fig. 5F). We hypothesize that Ser30b-Trp35 is the driver of the fibrillogenesis of Ser26-Arg39 peptide. 
Moreover, its strong propensity to form amyloid fibrils could drive larger fragments, and even the entire protein 
6aJL2, to adopt destabilized intermediate folding states, favouring amyloid formation. In the native protein, part 
of Ser26-Arg39 segment (sequence 29SIASN31) folds into a solvent exposed short α-helix, as part of the CDR1, 
while its C-terminal half extends into the β strand C, buried into the domain (Fig. S13). Such arrangement agrees 
with what has been observed regarding the spatial positioning of the amyloidogenic determinants in the globular 
proteins: (1) contrary to that could be expected, they are usually exposed to the solvent46, and (2) when exposed 
at the molecular surface, the amyloid-prone stretches are usually folded into an α-helix, a strategy utilised to 
hinder the contacts that lead to aggregation47. Although part of Ser26-Arg39 folds into an α-helix in the native 
context, this fragment readily forms β-sheet rich fibrils in isolation, as it was showed by Far-UV CD spectros-
copy (Fig. 4B). Such conformational ambivalence agrees with the prediction of similar non-native α-helix or 
β-sheet propensity that resulted from an analysis performed with CSSP248, a web tool optimized to calculate 
the contact-dependent secondary structure propensity49. It is also supported by the analysis performed with the 
web application Net-CSSP, optimized to find chameleon sequences in proteins, which detected that two discrete 
stretches, 29SIASN31 and 30bSNYVQ34, both contained in Ser26-Arg39, are in both α-helical and β-sheet contexts 
Figure 8. (A) Fibrillogenesis assay of the synthetic peptides with the sequence of the tryptic fragments of 
6aJL2. Transmission electron micrographs of the aggregates formed by the synthetic peptides (B) Ser26-
Arg39, (C) Ser26-Arg54, and (D) Phe62-Lys79 in the aggregation assay shown in panel (A). The images were 
obtained with a HITACHI-7100 transmission electron microscope. (E) Fibrillogenesis assay of the proteolytic 
fragment Thr18-Arg25-S-S-Thr80-Lys103 incubated in absence (T18-R25-S-S-T80-K103) or in presence of 
10 mM DTT (T18-R25-S-S-T80-K103 + DTT). Fragment Thr18-Arg25-S-S-Thr80-Lys103 was generated by 
proteolysis of soluble 6aJL2 protein with trypsin and then purified by RP-HPLC, as described in Methods. 
Transmission electron micrographs of the aggregates formed by the tryptic fragment Thr18-Arg25-S-S-
Thr80-Lys103 incubated in (F) absence or (G) in presence of 10 mM DTT, as shown in panel (E). The images 
were obtained with a CARL ZEISS Libra 120 transmission electron microscope. In (A) the data represented 
is the mean value ± S.D. of thioflavin T fluorescence emission at 482 nm of triplicate samples at the end of the 
experiment. In (E) the data represented is the mean ± 95 C.I. of the thioflavin T fluorescence emission at 482 nm 
of duplicated samples.
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in several native proteins (Fig. S13). This finding strongly suggests that these short sequences are conforma-
tionally flexible, being capable to adopt α or β conformation in a context-dependent manner, a hallmark of the 
chameleon sequences50. Hence, both theoretical and experimental data suggest that Ser26-Arg39 is a confor-
mationally flexible segment, containing sequence element that could be the “switch” triggering the α-helix to 
β-strand transition of the CDR1. Such transition could be part of a more general structural adjustment that could 
drive the self-assembly of 6aJL2 protein into amyloid-like fibrils. It is believed that α-helix to β-strand transitions 
driven by chameleon sequences play a key role in the amyloidogenesis of α helical proteins, as insulin46, apomy-
oglobulin51, and ApoA-I52.
The data obtained in this study prove the presence of a strongly fibrillogenic hot-spot spanning the CDR1 and 
β-strand C of 6aJL2. The fibrillar state promoted by such hot-spot is highly stable, since peptide Ser26-Arg39 was 
able to form fibrils even in 3.0 M of GdnHCl (Fig. S16). Consider that the Cm of reversible unfolding of 6aJL2 
protein in GdnHCl at 25 °C is 1.4 M17. This finding is consistent with the high propensity of the 6aJL2 protein to 
aggregate as amyloid-like fibrils in vitro. It has been shown that this protein efficiently forms fibrils under near 
physiological conditions of temperature, pH and ionic strength17,53. In addition, it was recently demonstrated 
that 6aJL2 and its point mutant 6aJL2-R25G are the proteins most prone to aggregation among a group of six 
rVL proteins encoded by the germ line of five VL gene segments that are associated to amyloid deposition24. It 
should be noted that 6aJL2 has the germline sequence of subgroup λ6, the family of light chains that shows 
the strongest association with amyloid deposition18–21,24. Hence, sequence elements contained in the segment 
Figure 9. Fibrillogenesis of the single mutants of the highly fibrillogenic peptide Ser26-Arg39 to proline 
(Scanning proline mutagenesis analysis). Panels (A,B) show the mean value plus the standard deviation of 
soluble fraction (blue squares) and ThT fluorescence (yellow circles) calculated from triplicates samples after 
(A) 16 hours and (B) 40 hours of incubation. Transmission electron micrographs of the aggregates formed by 
the point mutant peptides (C) Ser26Pro, (D) Ser27Pro, (E) Gly28Pro, (F) Ser29Pro, (G) Gln38Pro and (H) 
Arg39Pro. The scale bars represent 100 nm. The images were obtained with a HITACHI-7100 transmission 
electron microscope.
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Ile30-Gln37 are obvious candidates for the driver of the amyloid aggregation of 6aJL2. However, the role played 
by the aggregation-prone stretches in globular proteins depend not only on their “individual intrinsic aggrega-
bility”, but also accessibility to the molecular surface46,47, restriction imposed by the 3D folding of the protein54, 
and, in the case of the light chain, the effect of the somatic mutations55, could be dominants. Thus, it cannot be 
excluded that the hot-spot revealed in the fragments Thr18-Arg25-S-S-Thr80-Lys103 and Phe62-Lys79 play an 
important role in the fibrillogenesis of 6aJL2 protein, as well as in general for the λ6 light chains, representing 
potential target for theranostics agents.
In this study, the aggregation of 24 synthetic peptides structurally homologous to Ser26-Arg39, encoded by 
34 different VL gene segments, 23 κ and 11 λ, was monitored (Table S11). They represent roughly 50% of the 
sequence diversity encoded by the human germline VL repertoire56. It was found that 15 of them (60%) form 
fibrillar aggregates that gave positive ThT fluorescence (Fig. S12). This finding shows that a fibrillogenic hotspot 
associated to the CDR1 is a feature shared by light chains belonging to different κ and λ subgroups. Moreover, 
since the structure of the CDR1 is determined by both germline-encoded sequence elements as well as variations 
introduced by somatic hypermutation57,58, this finding also suggests a link between the evolution of the light 
chain gene segments and the mechanisms of diversification of antibody repertoire, on one hand, and the marked 
difference in amyloid propensity and pathogenic variability that characterizes light chains18,19,59,60, on the other. 
In this regard, comparative sequence alignment suggests that the inability of some Ser26-Arg39-homologous 
peptides to form fibrils is better explained by the presence of one or more charged residues (Asp, Glu, Arg and 
Lys) at positions potentially critical for fibril assembly (Fig. S14). The placement of such residues at a position 
involved in the fibril core would impose a desolvation energy penalty for self-assembly into fibrils that for some 
peptides could be large enough as to disfavour aggregation37,54. TEM analysis revealed a wide morphological het-
erogeneity of the aggregates formed by these peptides (Fig. 10), a finding that can be expected, given their large 
Figure 10. Transmission electron micrographs of the aggregates produced by the synthetic peptides with the 
sequence from position 26 to 39 of the human light chains, encoded by the VL gene segments (A–C) IGLV6-57 
(peptide λ6-6a), (D–F) IGLV1-36 (peptide λ1-1a), (G–I) IGLV1-40 (peptide λ1-1e), (J–L) IGLV2-14 (peptide 
λ2-2a2), (M–O) IGKV1-16 (peptide κ1-L1), (P–R) IGKV1-33 (κ1-018), and (S,T) IGKV4-1 (peptide κ4-
B3). The peptide sequence is shown in Table S11. The images were obtained with a CARL ZEISS Libra 120 
transmission electron microscope.
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structural heterogeneity, both in length and in sequence (Fig. S14). Interestingly, it appears not to be a correla-
tion between the propensity of the peptides to aggregate as amyloid-like fibrils and the frequency of the VL gene 
segment encoding them in AL amyloidosis (Table S11). In fact, it was found that the fraction of fibril-forming 
peptides of κ type (77%) was higher than that of λ type (41.6%), which contrasts with the well-known higher fre-
quency of λ light chains in amyloidosis61. Moreover, peptide λ3-3r, encoded by the AL-associated gene segment 
3r (IGLV3-1)20, did not form fibrils. These findings, in conjunction with others of this study, support the concept 
that the amyloidogenesis of the light chains is a complex process in which more than one amyloid-prone hotspot 
could drive the aggregation. Such concept is in line with the results of recent studies that used solid state nuclear 
magnetic resonance analysis for characterizing light chain fibrils, since they found that the segments of the pro-
tein that form the fibril core vary from one light chain to another62–64. Differences in the fibril core arrangement 
should be expected to translate into heterogeneity in morphology and biological properties of the aggregates. The 
interplay between the structural heterogeneity of the light chains and the amyloid aggregates that they form, on 
the one hand, and the genetic background of the patients on the other, would explain, at least in part, the great 
clinical heterogeneity that characterizes AL amyloidosis59. In agreement with this, it has been found that the usage 
of the repertoire of VL gene segments is linked to key clinical aspect of the AL amyloidosis18,19,65. Finally, this study 
could open the door to novel therapeutic approaches of AL amyloidosis, since the aggregation hotspots identified 
represent potential targets of ligands that could inhibit the amyloid aggregation of the light chains.
Conclusions
 1. Prediction-based approaches like those used in this study, could fail to detect fibrillogenic hotspots in 
protein’s regions that assemble into fibrils by mechanisms more complex than that driving the aggregation 
of self-complementary short peptides.
 2. The λ6 rVL protein 6aJL2 has several fibrillogenic hotspots. The hotspot spanning the CDR1 and the 
β-strand C is the most fibrillogenic of all.
 3. A fibrillogenic hotspot associated to the CDR1 is also present in other light chains belonging to different κ 
and λ VL subgroup.
Methods
Protein cloning, expression and purification. Cloning, bacterial expression and chromatographic puri-
fication of the germline λ6 rVL 6aJL2 protein has been described elsewhere17.
Identification of the fibrillogenic regions. Two different approaches were used to identify fibrillogenic/
aggregation-prone sequences in 6aJL2 protein (Fig. S1). In one of them, from now on named “prediction-based 
strategy”, the sequence of 6aJL2 protein was screened with two different web-based computational tools, 
Zipper-DB (http://services.mbi.ucla.edu/zipperdb/), and AmylPred-2 (http://aias.biol.uoa.gr/AMYLPRED2/). 
The first one computes fibrillogenic propensity using the structural-based algorithm 3D-profile method26. The 
Figure 11. Comparison of the sequences of 6aJL2 protein predicted to be fibrillogenic/aggregation-prone by 
the computational tools ZipperDB26 and AmylPred228 and the fibril-forming segments identified by the two 
different experimental strategies implemented in this study. Strategy 1 and 2 refer to the “prediction-based” 
and “proteolysis-based” strategies, respectively, which are described in detail in Methods. The segments of 
the protein folded as β-strand and α helix are represented as red arrows and green cylinders, respectively. The 
Framework (FR) and Complementarity Determining Regions (CDR) are indicated at the top of the figure. The 
sequence of protein 6aJL2 is shown in “one letter” code. The conserved intradomain disulphide bond Cys23-
Cys88 is shown as a dashed line in the sequence of 6aJL2 protein and in the tryptic fragment Thr18-Arg25-S-S-
Thr80-Lys103. The black curly bracket below the sequence SSGSIASNYVQWYQQR indicates the segment that 
proved to be sensitive to Pro mutation by scanning proline mutagenesis analysis.
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second one is a consensus method for predicting aggregation-prone regions in globular protein28. Then, the pre-
dictions generated by both tools were tested with a set of synthetic peptides named “prediction-based peptide 
library”, composed by 31 hexapeptides and one decapeptide (Table S2 and Fig. 3)29. In the second approach, 
known as “proteolysis-based strategy”, 6aJL2 protein was proteolyzed with trypsin, and the products incubated 
to promote the aggregation. The aggregates were collected by centrifugation at 14,000 r.p.m. in a table-top cen-
trifuge, resolubilized in 6.0 M guanidine hydrochloride (GdnHCl) and the components identified by combining 
RP-HPLC and MALDI-TOF mass spectrometry. Finally, the results were validated with a set of synthetic peptides 
with the sequence of the tryptic fragments (Fig. S8).
Aggregation assay with the prediction-based peptide library. Aliquots (300 µl) of synthetic pep-
tides dilutions (250 µM) in phosphate-buffered saline (PBS) pH 7.4 plus 0.05% w/v sodium azide were depos-
ited in 2 mL capped polypropylene microcentrifuge tubes (AXYGEN, Corning, NY, USA, Cat. No. MCT-200-C) 
and incubated for 24 hours at 37 °C with constant orbital shaking of 1000 r.p.m in a Thermomixer Comfort 
(EPPENDORF AG, Hamburg, Germany)29. The presence of amyloid-like aggregates was determined by the thi-
oflavin T (ThT) fluorescence assay66. An aliquot of the endpoint samples was withdrawn and stored at 4 °C for 
ultrastructural analysis by transmission electron microscopy (TEM). The same conditions were used to test the 
aggregation of the set of peptides with the sequence of the tryptic fragments of 6aJL2 (Fig. S8). The synthetic pep-
tides used in this study were purchased to GenScript (Genscript Biotech Corp., Piscataway, NJ 08854, USA) and 
they are more than 85% pure. Both purity and the correct mass of each peptide were determined by the provider 
by RP-HPLC and mass spectrometry analysis, respectively, as part of the normal quality control. A complete 
report of the process of quality evaluation of each peptide was provided to us by the GenScript.
Proteolysis of 6aJL2 with trypsin and fibrillogenesis of the tryptic fragments. A 3 mg/ml 
(250 µM) protein dilution in Tris-HCl 50 mM pH 8.0 was added with Trypsin Gold, mass spectrometry grade 
(Promega Corporation, Madison, USA) at a w/w protein/trypsin ratio of 200/1. Samples were incubated over-
night (~16 h) at 37 °C without agitation and then centrifuged at 25,000 r.p.m. at 4 °C for 30 min to sediment all 
preformed aggregates. An aliquot (600 µl) of the supernatant was carefully recovered and deposited in a 2 mL 
capped polypropylene microcentrifuge tubes (AXYGEN, Corning, NY, USA, Cat. No. MCT-200-C) and the 
aggregation assay was performed as described for the prediction-based peptide library, except that the agitation 
speed was set at 500 r.p.m. At time zero and at different incubation times, an aliquot (20 µl) was taken and the 
presence of amyloid aggregates determined by the ThT fluorescence assay66. At the same time, a second aliquot 
(50 µl) was withdrawn from the sample and centrifuged 25,000 g at 4 °C for 30 min to sediment the aggregates. The 
supernatant was carefully withdrawn, the pelleted aggregates washed with 100 µl of PBS pH 7.4, and sedimented 
again by centrifugation. The supernatant was discarded, and the pelleted aggregates resuspended in 100 µl of 6 M 
GdnHCl solution in miliQ water, with an incubation step of 15–20 min at 75 °C. Then, the sample was centrifuged 
as described before to eliminate any persisting aggregate and the supernatant was injected into an analytical 
Vydac 218TP53 C18 reverse phase column (GRACE, Columbia, Maryland, USA), installed in a Waters Alliance 
2695 HPLC system (Waters Corporation, Milford, Maryland, USA). The components absorbed to the column 
were eluted with a gradient of 0–60% of acetonitrile with 0.1% (v/v) TFA (solvent B) in miliQ-grade water with 
0.1% (v/v) TFA (solvent A) in 60 min, keeping the flow at 0.5 ml/min. The eluting fractions were detected by 
absorbance at 216 nm and fluorescence emission (excitation and emission wavelength of 295 nm and 350 nm, 
respectively) and were collected manually, dried in a rotary evaporator, and resuspended in an adequate volume. 
Then, they were mixed with the appropriated matrix, and the mass of the components of each fraction were 
determined by mass spectrometry in a 4800 PLUS MALDI TOF/TOF Analyzer (Applied Biosystems Inc, Foster 
City, California, USA).
Purification and fibrillogenesis of the recombinant fragment Thr18-Arg25-Thr80-lys103. Prot
eolysis of 6aJL2 protein with trypsin, fibrillogenesis of the product of proteolysis, and purification of the recombi-
nant fragment Thr18-Arg25-Thr80-Lys103 from the aggregates were performed as described in the previous par-
agraph. Once purified by RP-HPLC chromatography, the aggregation assay of the recombinant tryptic fragment 
was performed as described for the prediction-based peptide library, with two exceptions: (1) the concentration 
of the peptide was set at 150 μM; and (2) the aggregation of the fragment was evaluated in non-reducing (absence 
of DTT) and reducing (presence of 10 mM of DTT) conditions. The samples were assayed in duplicate.
Preparation of stable stock solution of the synthetic peptide Ser26-Arg39. All attempts to pre-
pare a stable solution of the synthetic peptide Ser26-Arg39 in PBS pH 7.5 or miliQ water were unsuccessful, 
since the peptide aggregates almost instantly. To solve this problem, the effect of GdnHCl on the solubility and 
aggregation of the peptide Ser26-Arg39 was investigated (Supplementary text S15). It was found that the pep-
tide Ser26-Arg39 forms amyloid-like aggregates in the presence of GdnHCl up to 3.0 M, being the aggregation 
totally inhibited at higher concentration of the denaturant (Fig. S16). Hence, the stock solution of the peptide 
Ser26-Arg39, as well as that of any other peptide whose aggregation would be compared to it, were prepared 
in PBS pH 7.4 plus 6.0 M GdnHCl. The peptide concentration was determined by UV spectroscopy, using the 
molar extinction coefficient at 280 nm calculated from the peptide sequence by the web-based tool PROTPARAM 
(https://web.expasy.org/protparam/). Then, working samples were prepared by diluting the stock solutions to 
reach the required GdnHCl concentration.
Scanning proline mutagenesis of the wild-type peptide Ser26-Arg39. The fibrillogenesis was 
monitored for the single mutants of peptide Ser26-Arg39 to Pro (Table S5) as described for the prediction-based 
peptide library, with the exception that the peptides were diluted at 150 µM in PBS pH 7.4 plus GdnHCl 2 M and 
the speed of orbital shaking was set at 500 r.p.m. Each peptide was assayed in triplicate. After 16 h and 40 h of 
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incubation, an aliquot (50 µl) was taken from each sample and the presence of amyloid-like aggregates was deter-
mined by the ThT fluorometric assay66. In parallel, a second aliquot was removed from the sample and centrifuged 
at 25,000 g for 30 min at 4 °C. An aliquot (20 µl) of the supernatant was carefully withdrawn, avoiding contami-
nation of the sedimented aggregates, and mixed with 1 ml of PBS pH 7.4. The intrinsic fluorescence of the sample 
was registered in the range from 310 nm to 410 nm, exciting the sample at 280 nm. The excitation and emission 
slits were set at 2 nm. Integration was performed every 1 nm. The aggregated fraction (A.F.) of each peptide at the 
time of analysis was calculated by the equation 1:
. . = − . . . .A F 1 (I F /I F ) (1)t t0
where I.F.t and I.F.t0 are the intrinsic fluorescence at a particular incubation time and time zero, respectively.
Aggregation assay of the set of Ser26-Arg39-homologous synthetic peptides. The 
amyloid-forming propensity of twenty-five synthetic peptides structurally homologous to peptide Ser26-Arg39, 
which are encoded by twelve λ and twenty-six κ germline VL gene segments was evaluated (Table S11). The fibril-
logenesis assay was performed as described for the prediction-based peptide library, with the exception that the 
peptide concentration was 150 µM, diluted in PBS pH 7.4 plus GdnHCl 1 M, and the speed of orbital shaking was 
set at 500 r.p.m. Each peptide was assayed in duplicate. After 24 hours of incubation, the presence of amyloid-like 
aggregates was determined by the ThT fluorescence assay66.
ThT fluorescence assay. The aliquots taken from the samples were mixed with 2 ml of a 20 µM ThT dilution 
in 50 mM TrisHCl pH 8.0. The ThT fluorescence, indicative of the presence of amyloid aggregates, was deter-
mined in the interval from 460 nm to 510 nm, exciting the sample at 450 nm. The excitation and emission slits 
were set at 2 nm. Integration was performed every 1 nm. All measurements of fluorescence (ThT and intrinsic 
fluorescence) were performed in a FluoroLog-3 spectrofluorometer (HORIBA INSTRUMENTS INC., Albany, 
New York, USA).
Transmission Electron Microscopy (TEM). The sample grids were prepared as previously described17. 
TEM images were obtained using a CARL ZEISS Libra 120 (Carl Zeiss AG, Oberkochen, Germany) or a 
HITACHI-7100 (Hitachi, Ltd, Tokyo, Japan) transmission electron microscope, in both cases running at 100 kV, 
coupled with a Gatan Ultrascan 1000 CCD (2000 × 2000 pixels) camera (GATAN, Pleasanton, California, USA) 
to record the images.
X-Ray Fiber Diffraction (XRFD). To produce material suitable for XRFD analysis, the peptides Ile30-Val33, 
Ser30b-Trp35, and Ile30-Gln37 were aggregated under the same conditions described for the prediction-based 
peptide library, but, instead of in PBS pH 7.4, the peptides were solubilized in milli-Q water plus 0.05% Na azide. 
The aggregates showing fibrillar characteristics after TEM imaging were aligned to obtain a fibrous-textured fibril 
prior to XRFD, according to method described previously67. XRFD was carried out in-house using a RIGAKU 
007 F CuKα rotating anode X-ray source (Rigaku Corporation, Tokio, Japan) running at 40 kW and 30 mA and 
a Saturn 944 + CCD detector (Rigaku Corporation, Tokio, Japan) (λ = 1.5419 Å, sample to detector distance 50 
and100 mm). The sample was placed upright in the path of the X-ray beam on a goniometer head, matching the 
fibre axis with the rotation axis of the sample plate. Diffraction data were initially observed using Mosflm68 and 
images were output as TIF files for further analysis. CLEARER software was used to measure the location of the 
diffraction peaks and to explore the dimensions of the unit cell. Raw diffraction patterns were centred and radi-
ally averaged prior to peak searching with the following settings: sample to detector plate distance D = 100 mm, 
default wavelength λ = 1.5419 Å and a pixel size of 179.1 µm. All other settings were set as default. Only the most 
intense peaks found using CLEARER were used for the unit cell prediction, and the initial guess for the unit cell 
was set as a = 4.7 Å b = 20 Å c = 20 Å, with a set as the fibre axis, b as the inter-sheet spacing and c as the chain 
length. The unit cell dimensions were optimized for b and c. For the diffraction pattern prediction, the same set-
tings were used, as well as a fibre disorder angle of 0.4 radians and a sampling interval of 1 pixel. The fibre axis was 
set parallel to the meridional axis of the diffraction patterns and the beam axis was set to be perpendicular to that 
axis. The calculated diffraction pattern generated from the determined unit cell was then compared back to the 
observed pattern, by superimposing a quadrant of the predicted pattern over the experimental diffraction pattern.
Far-UV Circular dichroism (CD) spectroscopy. Far-V CD was performed at 25 °C in a JASCO 710 
Spectropolarimeter (JASCO, Easton, MD 21601, USA) using a quartz cell with a light path of 0.1 cm, as described 
previously17.
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